StockGuru Blog: Tasco Holdings to Operate Adipose Derived Stem Cell Bank (from liposuction)
Tasco Holdings International (OTCBB: THII) has been rated “Outperform” with a target price of $6.00 by Beacon Equity Senior Research Analyst, Kris Goldcross, CFA. The full report is available at http://www.BeaconEquityResearch.com Tasco/Bio-Matrix may become the first company to operate an adipose-derived stem cell bank in the United States. Stem cells which are derived from fat tissues can easily, and ethically be harvested by elective liposuction, which is then stored in a frozen condition in liquid nitrogen at super-cooled temperatures. When needed, these stem cells can be thawed to potentially treat several diseases. The banking of cord blood is a once…